BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 6883184)

  • 41. In vitro effects of nonsteroidal anti-inflammatory agents and prostaglandins I2, E2, and F2alpha on contractility of taenia of the large colon of horses.
    Van Hoogmoed L; Rakestraw PC; Snyder JR; Harmon FA
    Am J Vet Res; 1999 Aug; 60(8):1004-9. PubMed ID: 10451213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of drugs on platelet function.
    Morse EE
    Ann Clin Lab Sci; 1977; 7(1):68-72. PubMed ID: 189670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapamycin enhances platelet aggregation induced by adenosine diphosphate in vitro.
    Wu Q; Huang KS; Chen M; Huang DJ
    Platelets; 2009 Sep; 20(6):428-31. PubMed ID: 19639515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists.
    Heath MF; Evans RJ; Hayes LJ
    Equine Vet J; 1998 Sep; 30(5):408-11. PubMed ID: 9758098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet function in leprosy.
    Gupta M; Bhargava M; Kumar S; Mittal MM
    Int J Lepr Other Mycobact Dis; 1975; 43(4):327-32. PubMed ID: 1241689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.
    Duz M; Parkin TD; Cullander RM; Marshall JF
    Am J Vet Res; 2015 Mar; 76(3):208-15. PubMed ID: 25710756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of pentoxifylline on equine platelet aggregation.
    Kornreich B; Enyeart M; Jesty SA; Nydam DV; Divers T
    J Vet Intern Med; 2010; 24(5):1196-202. PubMed ID: 20707843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH; Ruemmler R
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Intravenous Flunixin Meglumine, Phenylbutazone, and Acupuncture on Ocular Pain Scores in the Horse: A Pilot Study.
    Makra Z; Csereklye N; Riera MM; McMullen RJ; Veres-Nyéki K
    J Equine Vet Sci; 2021 Mar; 98():103375. PubMed ID: 33663725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of three nonsteroidal anti-inflammatory agents on platelet function and prostaglandin synthesis in vitro.
    McIntyre BA; Philp RB
    Thromb Res; 1978 Jan; 12(1):67-77. PubMed ID: 644561
    [No Abstract]   [Full Text] [Related]  

  • 55. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 56. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses.
    Semrad SD; Hardee GE; Hardee MM; Moore JN
    Equine Vet J; 1987 May; 19(3):201-6. PubMed ID: 3608957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.
    Henson PM
    J Clin Invest; 1977 Aug; 60(2):481-90. PubMed ID: 874106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
    Moses VS; Hardy J; Bertone AL; Weisbrode SE
    Am J Vet Res; 2001 Jan; 62(1):54-60. PubMed ID: 11197561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of a novel anti-inflammatory compound (AHI-805) on cyclooxygenase enzymes and the recovery of ischaemia injured equine jejunum ex vivo.
    Marshall JF; Bhatnagar AS; Bowman SG; Morris NN; Skorich DA; Redding CD; Blikslager AT
    Equine Vet J Suppl; 2011 Aug; (39):106-11. PubMed ID: 21790763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.